Approximately 1.5 million U.S. children face severe peanut allergies, which can trigger life-threatening reactions. A 2019 study showed promising results with Etokimab injections, but further research is needed on its efficacy and safety.
Tag: interleukin‑33 (IL‑33)
You must be logged in to post a comment.